The Role of Endoscopic Ultrasound in Assessing Tumor Response and Staging Post Neoadjuvant Chemotherapy in Esophageal Cancer

OBJECTIVE – Although the role of endoscopic ultrasound (EUS) in the initial staging of esophageal cancer is well established, its role in assessing tumor response and staging of esophageal cancers post neoadjuvant chemotherapy (NAC) is controversial and is the focus of this study.

METHODS AND PROCEDURES – A series of 77 patients with esophageal cancer who underwent EUS pre and post NAC were analyzed. All patients had NAC without radiation therapy. All cases were performed by a single surgeon. Tumor response was assessed pre and post NAC. Patients with greater than and less than 50% reduction in tumor size based on EUS evaluation were classified as having significant and partial response to chemotherapy respectively. The disease stage was established by using the Tumor (T), Nodes (N), Metastasis (M) classification system. The initial staging system was done with a combination of CT scans of the chest/abdomen and EUS. EUS determined cancer stage was compared with the post surgical pathologic stage for each patient. Data was analyzed utilizing Fisher’s exact test and Chi-square analysis.

RESULTS – 69 (89.6%) patients showed a response to NAC and eight (10.4%) patients had no response. 26/69 (37.7%) patients showed significant response and 43/69 (62.3%) patients showed partial response. The EUS staging correlated well with the pathological staging in six of the eight (75%) non-responders and in 23/69 (33.3%) of responders to NAC (p=0.04).

EUS accurately predicted both the T and N status in 12/77 (15.6%) patients. Predicting N status was significantly more accurate than T stage in post NAC patients. 29/77 (37.6%) patients had accurate T stage prediction and 43/77 (55.8%) patients had accurate N stage match (p=0.02). The T stage was overstaged in 45/77 (58.4%) and understaged in 3/77 (3.9%) patients. The N stage was overstaged in 18/77 (23.4%) and understaged in 16/77 (20.7%) patients.

CONCLUSION – EUS is a useful tool to assess response to chemotherapy and also in evaluating the extent of disease which will facilitate surgical decision making.However EUS is an unreliable tool for staging esophageal cancer after NAC. Overstaging of the T stage is significantly more common and could be related to the inflammatory effect or fibrosis post NAC.

Session: Poster

Program Number: P322

View Poster

« Return to SAGES 2010 abstract archive